Oil prices steady near 1-mth high on US-Iran sanctions; OPEC+ meeting awaited
Blend Labs, Inc. NASDAQ:BLND Head of Blend, Nima Ghamsari, sold 311,886 shares of Class A Common Stock on August 14, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a price of $2.90, for a total transaction value of $904,469. The stock has since risen to $3.05, showing an 8.16% gain over the past week, according to InvestingPro data.
Following the transaction, Ghamsari directly owns 5,754,051 shares of Blend Labs, Inc. With analysts setting price targets ranging from $3.50 to $7.00, this fintech company, currently valued at approximately $799 million, maintains a strong liquidity position with a current ratio of 2.4. For deeper insights into insider trading patterns and comprehensive analysis, check out the detailed Pro Research Report available on InvestingPro.
The filing indicates that the shares were transferred to a lender in lieu of payments due under personal loans. The sale was reported on August 18, 2025, with Winnie Ling, Attorney-in-fact, signing on Ghamsari’s behalf.
In other recent news, Blend Labs, Inc. has been active with multiple developments. The company announced an expanded partnership with Doma Technology, LLC, integrating Doma’s AI-powered instant title decisioning into Blend’s home lending platform. This collaboration is designed to create a seamless digital title and closing process, potentially reducing title insurance costs for borrowers by up to 70%. Additionally, Blend Labs has entered into a definitive agreement to sell its Title365 unit to Covius Services, LLC, pending regulatory approvals. This acquisition is expected to enhance Covius’ title insurance services across 43 states.
In leadership news, Blend Labs appointed Reva Rao as Head of Digital Transformation for Credit Unions, bringing over 20 years of experience in the financial sector. Analyst activity has also been notable, with Citizens JMP maintaining a Market Outperform rating and a $7 price target for Blend Labs, following positive investor meetings. Meanwhile, Keefe, Bruyette & Woods (KBW) raised their price target for Blend Labs to $4, citing improved financial performance and a cleaner outlook. Despite a slight shortfall in second-quarter revenue guidance, Blend Labs reported significant growth in first-quarter closings and a substantial increase in its pipeline and performance obligations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.